Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1763 (LINC01763) is a non-coding RNA gene transcribed in humans. It belongs to the class of long intergenic non-protein coding RNAs (lincRNAs), which are >200 nucleotides in length and located between protein-coding genes in the genome[1][3]. LincRNAs are recognized for their diverse regulatory roles, including chromatin remodeling, transcriptional modulation, and enhancer-associated activities, often exhibiting tissue specificity and context-dependent functions[3]. However, LINC01763 itself is a relatively uncharacterized lincRNA: as of now, there are no detailed studies describing its unique molecular interactions, biological activities, associated disorders, or direct involvement in any human disease. It is included in genomic and bioinformatic databases, but evidence for clinical relevance or therapeutic targeting is absent[1].
No known mechanisms of action for drugs targeting this molecule.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1763 (LINC01763).